153 related articles for article (PubMed ID: 26205450)
1. Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption.
Suwannasom P; Onuma Y; Campos CM; Nakatani S; Ishibashi Y; Tateishi H; Grundeken MJ; Stanetic B; Nieman K; Jonker H; Garcia-Garcia HM; Serruys PW;
JACC Cardiovasc Interv; 2015 Jul; 8(8):1130-1132. PubMed ID: 26205450
[No Abstract] [Full Text] [Related]
2. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
[TBL] [Abstract][Full Text] [Related]
3. Early neoatherosclerosis after bioresorbable vascular scaffold implantation: insights from optical coherence tomography.
Sato T; Richardt G; Abdel-Wahab M
Coron Artery Dis; 2016 Nov; 27(7):616-7. PubMed ID: 27228185
[No Abstract] [Full Text] [Related]
4. Accuracy of coronary computed tomography angiography for bioresorbable scaffold luminal investigation: a comparison with optical coherence tomography.
Collet C; Sotomi Y; Cavalcante R; Asano T; Miyazaki Y; Tenekecioglu E; Kistlaar P; Zeng Y; Suwanasson P; de Winter RJ; Nieman K; Serruys PW; Onuma Y
Int J Cardiovasc Imaging; 2017 Mar; 33(3):431-439. PubMed ID: 27896495
[TBL] [Abstract][Full Text] [Related]
5. Persistent Bioresorbable Vascular Scaffold by Optical Coherence Tomography Imaging at 5 Years.
Moriyama N; Shishido K; Tobita K; Takada T; Ochiai T; Tsukuda S; Yamanaka F; Sugitatsu K; Mizuno S; Tanaka Y; Murakami M; Matsumi J; Takahashi S; Akasaka T; Saito S
JACC Cardiovasc Interv; 2017 Jan; 10(2):e11-e13. PubMed ID: 28040440
[No Abstract] [Full Text] [Related]
6. Very Late Restenosis Following Bioresorbable Scaffold Implantation.
Okuno T; Yahagi K; Horiuchi Y; Aoki J; Simonton CA; Rapoza R; Saito S; Kimura T; Tanabe K
JACC Cardiovasc Interv; 2017 Sep; 10(18):e167-e169. PubMed ID: 28866033
[No Abstract] [Full Text] [Related]
7. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.
Bourantas CV; Serruys PW; Nakatani S; Zhang YJ; Farooq V; Diletti R; Ligthart J; Sheehy A; van Geuns RJ; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Rapoza R; Veldhof S; Onuma Y; Garcia-Garcia HM
EuroIntervention; 2015 Nov; 11(7):746-56. PubMed ID: 25308301
[TBL] [Abstract][Full Text] [Related]
8. Novel 3-Dimensional Vessel and Scaffold Reconstruction Methodology for the Assessment of Strut-Level Wall Shear Stress After Deployment of Bioresorbable Vascular Scaffolds From the ABSORB III Imaging Substudy.
Gogas BD; Yang B; Piccinelli M; Giddens DP; King SB; Kereiakes DJ; Ellis SG; Stone GW; Veneziani A; Samady H
JACC Cardiovasc Interv; 2016 Mar; 9(5):501-3. PubMed ID: 26965940
[No Abstract] [Full Text] [Related]
9. Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold at 8 Months.
Kang SH; Kang SJ; Kim WJ
JACC Cardiovasc Interv; 2017 Sep; 10(18):1896-1898. PubMed ID: 28866035
[No Abstract] [Full Text] [Related]
10. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
[No Abstract] [Full Text] [Related]
11. Very late metallic stent malapposition and in-stent restenosis treated with a bioresorbable scaffold: a novel alternative for an old problem.
Foin N; Lee R; Wong P; Low AF
EuroIntervention; 2015 Aug; 11(4):e1. PubMed ID: 26298237
[No Abstract] [Full Text] [Related]
12. Development and receding of a coronary artery aneurysm after implantation of a fully bioresorbable scaffold.
Nakatani S; Ishibashi Y; Suwannasom P; Grundeken MJ; Høj Christiansen E; Onuma Y; Serruys PW;
Circulation; 2015 Feb; 131(8):764-7. PubMed ID: 25712060
[No Abstract] [Full Text] [Related]
13. Bioresorbable Scaffolds for the Management of Coronary Bifurcation Lesions.
Kawamoto H; Ruparelia N; Tanaka A; Chieffo A; Latib A; Colombo A
JACC Cardiovasc Interv; 2016 May; 9(10):989-1000. PubMed ID: 27198679
[TBL] [Abstract][Full Text] [Related]
14. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
[TBL] [Abstract][Full Text] [Related]
15. Contrast leak mimicking detector malfunction in coronary artery calcium scoring.
Makaryus JN; Saba SG; Makaryus AN
J Cardiovasc Comput Tomogr; 2015; 9(6):597-8. PubMed ID: 26198264
[No Abstract] [Full Text] [Related]
16. Fate of side-branch jailing and a malapposed platinum marker after resorption of an everolimus-eluting bioresorbable vascular scaffold: serial optical coherence tomography observations.
Karanasos A; Garcia-Garcia HM; van Geuns RJ; Regar E
JACC Cardiovasc Interv; 2015 Mar; 8(3):e53-e54. PubMed ID: 25790767
[No Abstract] [Full Text] [Related]
17. Very Late Restenosis After Bioresorbable Scaffold Implantation Due to Simultaneous External Compression of the Scaffold and Intrascaffold Tissue Growth.
Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
JACC Cardiovasc Interv; 2016 Jan; 9(2):e15-7. PubMed ID: 26723762
[No Abstract] [Full Text] [Related]
18. An Unusual Complication After Bioresorbable Scaffold Implantation: Visualization of Intramural Hematoma by Optical Coherence Tomography.
Zhang BC; Karanasos A; Royaards KJ; Ligthart J; Regar E
JACC Cardiovasc Interv; 2015 Aug; 8(9):e143-e145. PubMed ID: 26292606
[No Abstract] [Full Text] [Related]
19. Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II).
Ishibashi Y; Nakatani S; Sotomi Y; Suwannasom P; Grundeken MJ; Garcia-Garcia HM; Bartorelli AL; Whitbourn R; Chevalier B; Abizaid A; Ormiston JA; Rapoza RJ; Veldhof S; Onuma Y; Serruys PW
JACC Cardiovasc Interv; 2015 Nov; 8(13):1715-26. PubMed ID: 26585622
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.
Ishibashi Y; Muramatsu T; Nakatani S; Sotomi Y; Suwannasom P; Grundeken MJ; Cho YK; Garcia-Garcia HM; van Boven AJ; Piek JJ; Sabaté M; Helqvist S; Baumbach A; McClean D; de Sousa Almeida M; Wasungu L; Miquel-Hebert K; Dudek D; Chevalier B; Onuma Y; Serruys PW
JACC Cardiovasc Interv; 2015 Jul; 8(8):1053-1063. PubMed ID: 26205444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
